Beijing [China], November 19 (ANI): Indian and Chinese officials will have "communication and coordination" to discuss cooperation to develop COVID-19 vaccine, said Chinese foreign ministry, a day after President Xi Jinping said his country is ready to cooperate with New Delhi on vaccine dev
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F
Madrid [Spain], November 18 (ANI/Sputnik): The Spanish Agency of Medicines and Medical Devices (AEMPS) authorized phase 3 clinical trials of the COVID-19 vaccine developed by Janssen, a subsidiary of the Johnson & Johnson company, the Spanish Health Ministry said on Wednesday.
Washington [US], November 18 (ANI): American drug giant Pfizer on Wednesday said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people.
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Beijing [China], November 18 (ANI): China is prepared to cooperate with India and other BRICS nations in the development of vaccines against COVID-19, said Chinese President Xi Jinping as he proposed to convene a BRICS symposium on traditional medicine to explore its role in coronavirus prev
New Delhi [India], November 18 (ANI): The Union Health Ministry on Tuesday said that the central government is examining all possibilities to extend cold chain facilities in case Pfizer's COVID-19 vaccine needs to be procured.
Washington [US], November 17 (ANI): US President-elect Joe Biden on Monday (local time) asked President Donald Trump-led administration to make co-ordinated plans for nationwide coronavirus vaccination or more people will die due to the infection.
New Delhi[India], Nov 16 (ANI) Indian government is in dialogue with US biotech giant Moderna, regarding initial successful development of its COVID-19 vaccine candidate, which the drugmaker on Monday announced had achieved 94.5 per cent efficacy in phase 3 trials.
Washington DC [US], November 16 (ANI): US Vice President-elect Kamala Harris on Monday said that Joe Biden's administration would get COVID-19 under control in the country which has crossed the 11 million mark.
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.